These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3867783)

  • 1. Plasmapheresis holds distinct advantages for 21st century uremia therapy.
    Nose Y; Smith JW; Malchesky PS
    Kidney Int Suppl; 1985 Dec; 17():S131-2. PubMed ID: 3867783
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune system dysregulation in uremia.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Zingraff J; Jungers P; Chatenoud L
    Semin Nephrol; 1994 May; 14(3):253-60. PubMed ID: 8036360
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of plasmapheresis in treating urology patients].
    Neĭmark AI; Astakhov IuI; Davydov AV; Mazyrko AV; Iakovets IaV
    Ter Arkh; 1993; 65(10):83-6. PubMed ID: 8296244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The correction of the immune disorders in patients with chronic pyelonephritis and chronic kidney failure].
    Neĭmark AI; Iakovets IaV
    Urol Nefrol (Mosk); 1994; (5):22-4. PubMed ID: 7532880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immune defect in kidney failure. II. The mechanisms of the "uremic" immune defect].
    Köhler H; Girndt M; Dumann H; Klingel R
    Dtsch Med Wochenschr; 1993 May; 118(21):790-5. PubMed ID: 8504715
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sepsis in patients with terminal chronic kidney failure (a review of the literature)].
    Filiptsev PIa; Vetchinnikova ON; Cherniakov VL
    Khirurgiia (Mosk); 1988 Mar; (3):131-7. PubMed ID: 3290567
    [No Abstract]   [Full Text] [Related]  

  • 8. Forces determining selection of uremia therapy.
    Friedman EA; Lundin AP
    Adv Nephrol Necker Hosp; 1984; 13():151-62. PubMed ID: 6433665
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune disorders in hemodialysis patients.
    Sharif MR; Chitsazian Z; Moosavian M; Raygan F; Nikoueinejad H; Sharif AR; Einollahi B
    Iran J Kidney Dis; 2015 Mar; 9(2):84-96. PubMed ID: 25851286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hyperhydrated states by means of hemofiltration].
    Levitskiĭ ER; Baeva LB; Dmitriev AA; Volkova NA; Salagaeva AB
    Sov Med; 1978 Oct; (10):65-8. PubMed ID: 715538
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological parameters in uremic patients under hemodialysis].
    Pigareva NV; Polenova IM
    Klin Med (Mosk); 1981 Mar; 59(3):75-9. PubMed ID: 7265837
    [No Abstract]   [Full Text] [Related]  

  • 12. Problems and solutions for artificial kidney.
    Vanholder R
    Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemofiltration-technique and clinical application.
    Quellhorst E; Scheunemann B; Hildebrand U
    Int J Artif Organs; 1980 Jul; 3(4):209-10. PubMed ID: 7409916
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemoperfusion for uremia: past, present, and future.
    Winchester JF; Ash SR
    Kidney Int Suppl; 1985 Dec; 17():S127-30. PubMed ID: 3867782
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of isolated ultrafiltration in patients with protracted uremia].
    Luciak M
    Pol Tyg Lek; 1982 Apr; 37(4-5):135-7. PubMed ID: 7050944
    [No Abstract]   [Full Text] [Related]  

  • 16. Current trends in dialysis therapy.
    Jacobs C
    Kidney Int Suppl; 1997 Nov; 62():S93-5. PubMed ID: 9350692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological monitoring of chronic hemodialysis].
    Gidenne S; Ceppa F; Robino C; Sarret D; Burnat P
    Ann Biol Clin (Paris); 2000; 58(6):663-74. PubMed ID: 11098163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis and transplant patients in the long term.
    Bonomini V; Scolari MP; Stefoni S; Vangelista A
    Ann Ital Med Int; 1993; 8(2):73-9. PubMed ID: 8353022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic alterations associated with chronic hemodialysis.
    Rus HG; Cristea A; Gherman M; Niculescu F; Gavan M
    Med Interne; 1983; 21(4):289-95. PubMed ID: 6658343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.
    Jørstad S; Smeby LC; Widerøe TE; Berg KJ
    Clin Nephrol; 1980 Feb; 13(2):85-92. PubMed ID: 6988123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.